BMC Urology works with with Cochrane Urology in providing our authors with expert advice on systematic reviews and meta-analyses
Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer
We propose to improve the prognostic assessment after radical prostatectomy (RP) by dividing high-risk prostate cancer (hrPCa) (according to the d’Amico classification) into subgroups combining 1, 2 or 3 crite...